---
schema_version: "secwatch.filing_event.v1"
accession: "0001729149-25-000055"
form_type: "8-K"
ticker: "VMD"
cik: "0001729149"
company_name: "VIEMED HEALTHCARE, INC."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T01:48:50.521961+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "medium"
source: SEC EDGAR
---

# Viemed posts record Q4 revenue $60.7M; full year net revenue $224.3M; issues 2025 guidance

## Summary
- Q4 net revenue $60.7M (+20% YoY); full year $224.3M (+23% YoY).
- Q4 diluted EPS $0.10 (net income $4.3M); full year EPS $0.28.
- Adjusted EBITDA Q4 $14.2M; full year record $51.1M.
- Ventilator patients 11,795 (+14% YoY); PAP therapy 21,338 (+43% YoY).
- Issued fiscal 2025 guidance; specific targets not included in filing.

## SEC filing metadata
- accession: 0001729149-25-000055
- form_type: 8-K
- ticker: VMD
- cik: 0001729149
- company_name: VIEMED HEALTHCARE, INC.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: medium
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000055/0001729149-25-000055-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729149/000172914925000055/vmd-20250310.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001729149-25-000055
- JSON: https://secwatch.observer/filing/0001729149-25-000055.json
- Plain text: https://secwatch.observer/filing/0001729149-25-000055.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.